Menu

CMS

CMS' recent request for information on Medicare Part D pharmacy contract terms included a specific question on 340B.

CMS RFI Raises Provider Questions About 340B Part D Reimbursement

October 1, 2026 William Newton, Editor-in-Chief 340B Report Views

CMS recently solicited feedback on Medicare Part D pharmacy contract terms involving 340B drugs, raising questions among provider attorneys about [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton

HRSA, PhRMA Urge Fed Appeals Court to Overturn 340B Hospital Child Site Ruling

HRSA Approves 10 Drugmaker Plans for 2027 340B Rebate Pilot